)
Hyderabad-based bio pharmaceutical company Suven Life Sciences has reported a 11.55% decline in net profit at Rs 32.2 crore for the quarter ended December, 2014 as compared with Rs 36.4 crore in the corresponding quarter previous year.
The company revenues, however, increased 9% to Rs 131.1 crore from Rs 120.3 crore in the year ago period. Net profit for the third quarter ended December, 2014 was reduced due to charge of additional depreciation computed as per Schedule II of the Companies Act 2013 effective April 1, 2014, shown, according to the company.
